urse-led hematuria (blood in urine) clinic – a prospective trial

Not Applicable

• Conditions: Macroscopic hematuria; Urological and Genital Diseases

• Registration Number: ISRCTN15685750
• Lead Sponsor: Skåne University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-02-20
• Last Update Posted: 6 March 2023
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: Female
• Target Recruitment: 800

Inclusion Criteria

1. Female
2. Hematuria referral
3. Aged 50 years or older

Exclusion Criteria

1. Age below 50 years
2. Lack of informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time from hematuria to cystoscopy/bladder cancer diagnosis measured using patient records.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Patient reported experience measures (PREM): urography or cystoscopy PREM - Validated national questionnaire for patient-reported outcomes - filled in by patient after cystoscopy<br> 2. Cost effectiveness measured using EQ-5D-5L and direct costs extracted from patient charts at the end of the study<br> 3. Sensitivity and specificity for the IB-test to detect bladder cancer measured by comparing the IB test result to the actual outcome (positive or negative) at the end of the study<br>